NR1H4 and diabetic kidney disease: Whether improving glucose and lipid metabolism or modulating energy metabolism or directly activating renal bile acid receptors, bile acids are closely related to the prognosis of DKD patients; therefore, bile acid analogs are likely to become a new treatment for DKD.